CAS has a formal policy regarding the need for authors and presenters to inform Annual Meeting attendees of any Conflict of Interest (COI). A COI includes, but is not limited to, employment, ownership of stock, membership on a standing advisory council or committee, or being on the board of directors or publicly associated with a company or its products.
Other potential areas of real or perceived conflict of interest could include receiving honoraria, consulting fees, or grants.
Dr Daniel Bainbridge     
Archytype Medical - Shareholder
Heron Therapeutics - Advisory board
CAS - President
Dr AndrĂ© Bernard           
Doctors NS, nonprofit – Board Chair (honorarium)
CMA, nonprofit – Health Summit Planning Committee & Advisory Board on International Health honorarium)
Dr Jeff Gadsden
Pacira Biosciences – Ad hoc consultant
Mallinckrodt Pharmaceuticals – research funding
Dr Kwesi Kwofie             
Sonosite/FujiFilm – unrestricted equipment support for research and educational projects.
Dr Susan Moffatt-Bruce
LifeWings Inc. – speaker
AHRQ/NIH – Principal Investigator/ Co-Principal Investigator
Dr Duminda Wijeysundera
Heron Therapeutics – Attended advisory board meeting (Oct 2019)
Dr Camilla Wong
North East Specialized Geriatrics Centre – Speaker Honoraria
Regional Geriatric Program of Eastern Ontario – Speaker Honoraria
Hong Kong Health Authority – Speaker Honoraria
Ministry of Health and Long-Term Care of Ontario – Innovation Grant